Great Saphenous Vein Disease: Evaluation and Treatment
For symptomatic great saphenous vein (GSV) incompetence with documented reflux, endovenous thermal ablation (radiofrequency or laser) is the first-line treatment and should not be delayed for a trial of compression therapy. 1
Initial Diagnostic Evaluation
Start with duplex ultrasound of the lower extremity as the definitive diagnostic test 2. This is non-negotiable and universally appropriate for initial diagnosis.
Key Ultrasound Findings to Document:
- Reflux duration: >1000 ms at saphenofemoral junction (SFJ) or >500 ms elsewhere defines pathologic reflux 3
- Vein diameter: Measure at multiple segments (SFJ, proximal thigh, mid-thigh, knee, calf) 3
- Anatomic distribution: Map the entire superficial venous system including tributaries and perforators
- Deep vein patency: Rule out obstruction or post-thrombotic changes
Clinical Severity Classification:
Use CEAP classification to guide treatment intensity 2:
- C2-C3 (varicose veins ± edema): 25% prevalence
- C4-C6 (skin changes/ulceration): 5% prevalence, requires more aggressive intervention
Treatment Algorithm
For C2-C5 Disease (Primary GSV Incompetence):
First-Line: Endovenous Thermal Ablation
- Radiofrequency ablation (RFA) or endovenous laser ablation (EVLA) are equivalent first choices 1, 4
- RFA may offer slightly better long-term outcomes (lower recurrence at 5 years: OR 0.41) 4
- Both provide 88% anatomical success at 5 years 5
- Same-day discharge, rapid return to work, local anesthesia only 1
- Critical advantage: 7% risk of temporary nerve injury vs. higher surgical morbidity 1
Second-Line: Foam Sclerotherapy
- Reserve for smaller veins (1-5 mm) or recurrent disease 1
- Significantly inferior for truncal GSV: only 34% success at 5 years vs. 88% for thermal ablation 5
- Higher SFJ recurrence (29% vs. 12% for surgery) 5
Third-Line: High Ligation and Stripping (HL&S)
- Consider when endovenous options fail or are unavailable 1
- Best long-term freedom from failure in C2-C5 disease (HR 2.64 vs. RFA) 6
- Lowest SFJ recurrence (12% at 5 years) 5
- Trade-offs: Higher ecchymosis (76%), infection risk (2.35%), slower recovery 6
- 20-28% recurrence at 5 years overall 1
For Below-Knee GSV Incompetence:
Prefer non-thermal non-tumescent techniques to avoid nerve injury 7:
- Cyanoacrylate glue closure
- Mechanochemical ablation (MOCA)
- These eliminate thermal nerve damage risk in anatomically vulnerable areas
For Venous Ulcers (C5-C6):
Mandatory dual approach 2:
- Compression therapy as primary wound healing modality
- Saphenous vein ablation to prevent recurrence (reduces recurrence significantly) 8
- Consider perforator treatment if diameter ≥3.5 mm with outward flow ≥500 ms beneath ulcer 8
Special Populations:
Pregnancy:
- Compression therapy only (20-30 mmHg gradient stockings) 1
- Defer ablation until postpartum
Pelvic-origin varicosities in females:
- Conservative management first-line 2
- Saphenous ablation controversial in this subset
Common Pitfalls to Avoid
- Don't require compression trial before ablation - This delays definitive treatment without benefit 1
- Don't use foam sclerotherapy for large truncal GSV - 66% failure rate at 5 years 5
- Don't ignore perforators in ulcer patients - Treat pathologic perforators (≥3.5 mm, ≥500 ms reflux) beneath C5-C6 ulcers 8
- Don't perform surgery as first-line - Reserve for failed endovenous treatment 1
Complementary Procedures
Often performed simultaneously 2:
- Microphlebectomy for tributary varicosities
- Compression sclerotherapy for residual veins
- These are complementary, not alternatives
Quality of Life Considerations
All interventions show comparable QoL improvement at follow-up 4. However, minimally invasive procedures offer faster return to normal activities (days vs. weeks for surgery) 6, which significantly impacts patient satisfaction and lost productivity—critical for working-age patients.
The evidence strongly favors endovenous thermal ablation as the optimal balance of efficacy, safety, and recovery for most patients with GSV incompetence.